623 related articles for article (PubMed ID: 15466214)
21. The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function.
Comuzzi B; Lambrinidis L; Rogatsch H; Godoy-Tundidor S; Knezevic N; Krhen I; Marekovic Z; Bartsch G; Klocker H; Hobisch A; Culig Z
Am J Pathol; 2003 Jan; 162(1):233-41. PubMed ID: 12507906
[TBL] [Abstract][Full Text] [Related]
22. Growth regulation and cellular changes during differentiation of human prostatic cancer LNCaP cells as induced by T lymphocyte-conditioned medium.
Hsieh TC; Xu W; Chiao JW
Exp Cell Res; 1995 May; 218(1):137-43. PubMed ID: 7537687
[TBL] [Abstract][Full Text] [Related]
23. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein.
Rowan BG; Garrison N; Weigel NL; O'Malley BW
Mol Cell Biol; 2000 Dec; 20(23):8720-30. PubMed ID: 11073973
[TBL] [Abstract][Full Text] [Related]
24. Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells.
Tang YQ; Han BM; Yao XQ; Hong Y; Wang Y; Zhao FJ; Yu SQ; Sun XW; Xia SJ
Asian J Androl; 2009 Jan; 11(1):119-26. PubMed ID: 19050678
[TBL] [Abstract][Full Text] [Related]
25. Specific region in hormone binding domain is essential for hormone binding and trans-activation by human androgen receptor.
Govindan MV
Mol Endocrinol; 1990 Mar; 4(3):417-27. PubMed ID: 2342476
[TBL] [Abstract][Full Text] [Related]
26. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation.
Migliaccio A; Castoria G; Di Domenico M; de Falco A; Bilancio A; Lombardi M; Barone MV; Ametrano D; Zannini MS; Abbondanza C; Auricchio F
EMBO J; 2000 Oct; 19(20):5406-17. PubMed ID: 11032808
[TBL] [Abstract][Full Text] [Related]
27. Target gene-specific regulation of androgen receptor activity by p42/p44 mitogen-activated protein kinase.
Agoulnik IU; Bingman WE; Nakka M; Li W; Wang Q; Liu XS; Brown M; Weigel NL
Mol Endocrinol; 2008 Nov; 22(11):2420-32. PubMed ID: 18787043
[TBL] [Abstract][Full Text] [Related]
28. Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.
Xu D; Lin TH; Li S; Da J; Wen XQ; Ding J; Chang C; Yeh S
Cancer Lett; 2012 Mar; 316(1):11-22. PubMed ID: 22154085
[TBL] [Abstract][Full Text] [Related]
29. Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines.
Chen H; Libertini SJ; George M; Dandekar S; Tepper CG; Al-Bataina B; Kung HJ; Ghosh PM; Mudryj M
Endocr Relat Cancer; 2010 Dec; 17(4):857-73. PubMed ID: 20634343
[TBL] [Abstract][Full Text] [Related]
30. Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells.
Damassa DA; Lin TM; Sonnenschein C; Soto AM
Endocrinology; 1991 Jul; 129(1):75-84. PubMed ID: 2055206
[TBL] [Abstract][Full Text] [Related]
31. Local hyperthermia for prostatic disease: in vitro studies on human prostatic cancer cell lines.
Lloyd SN; Chalmers D; Leake RE; Kirk D
Br J Urol; 1992 Nov; 70(5):529-33. PubMed ID: 1467861
[TBL] [Abstract][Full Text] [Related]
32. Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation.
Veldscholte J; Berrevoets CA; Brinkmann AO; Grootegoed JA; Mulder E
Biochemistry; 1992 Mar; 31(8):2393-9. PubMed ID: 1540595
[TBL] [Abstract][Full Text] [Related]
33. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.
Bruchovsky N; Rennie PS; Otal N; Vanson A; Giles M; Pontifex H
Cancer Res; 1985 Feb; 45(2):682-9. PubMed ID: 3967243
[TBL] [Abstract][Full Text] [Related]
34. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion.
Li Y; Wang L; Zhang M; Melamed J; Liu X; Reiter R; Wei J; Peng Y; Zou X; Pellicer A; Garabedian MJ; Ferrari A; Lee P
Cancer Res; 2009 Apr; 69(8):3332-8. PubMed ID: 19351848
[TBL] [Abstract][Full Text] [Related]
35. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone and antihormone specificity in gene transactivation.
Kokontis J; Ito K; Hiipakka RA; Liao S
Receptor; 1991; 1(4):271-9. PubMed ID: 1668832
[TBL] [Abstract][Full Text] [Related]
36. The neuroendocrine-derived peptide parathyroid hormone-related protein promotes prostate cancer cell growth by stabilizing the androgen receptor.
DaSilva J; Gioeli D; Weber MJ; Parsons SJ
Cancer Res; 2009 Sep; 69(18):7402-11. PubMed ID: 19706771
[TBL] [Abstract][Full Text] [Related]
37. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.
Fancher AT; Hua Y; Close DA; Xu W; McDermott LA; Strock CJ; Santiago U; Camacho CJ; Johnston PA
SLAS Discov; 2023 Oct; 28(7):325-343. PubMed ID: 37549772
[TBL] [Abstract][Full Text] [Related]
38. Effects of androgen withdrawal on the stem cell composition of the Shionogi carcinoma.
Bruchovsky N; Rennie PS; Coldman AJ; Goldenberg SL; To M; Lawson D
Cancer Res; 1990 Apr; 50(8):2275-82. PubMed ID: 2317815
[TBL] [Abstract][Full Text] [Related]
39. Androgen receptor transcriptional activity is required for heregulin-1β-mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase.
Jathal MK; Siddiqui S; Vasilatis DM; Durbin Johnson BP; Drake C; Mooso BA; D'Abronzo LS; Batra N; Mudryj M; Ghosh PM
J Biol Chem; 2023 Aug; 299(8):104973. PubMed ID: 37380074
[TBL] [Abstract][Full Text] [Related]
40. Activation of Rac1 is closely related to androgen-independent cell proliferation of prostate cancer cells both in vitro and in vivo.
Kobayashi T; Inoue T; Shimizu Y; Terada N; Maeno A; Kajita Y; Yamasaki T; Kamba T; Toda Y; Mikami Y; Yamada T; Kamoto T; Ogawa O; Nakamura E
Mol Endocrinol; 2010 Apr; 24(4):722-34. PubMed ID: 20203103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
